Home › Respiratory Syncytial Virus Infections › North Carolina
Respiratory Syncytial Virus Infections clinical trials in North Carolina
3 studies for Respiratory Syncytial Virus Infections are looking for participants at sites in North Carolina.
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
- Progressive Medicine of the Triad, LLC, Winston-Salem
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07214571A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
- Duke University - Main Hospital and Clinics, Durham
- Duke University - Main Hospital and Clinics, Durham
RecruitingPhase 3Healthy volunteers welcome
Ages 0 and older · All sexes · Updated Sep 24, 2026 · NCT06866405Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 3
3 Days – 2 Years · All sexes · Updated Feb 9, 2026 · NCT05026749From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.